Clinical Trial of BioBlock COVID-19 Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived From Bovine Colostrum

Clinical trial NCT04916574 · COMPLETED

Trial details

NCT number: NCT04916574
Sponsor: Icosagen Cell Factory
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

SARS-COV2 Infection Covid19

Start date: 2021-03-20
Primary completion: 2021-03-28
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.